Ratings Farmacosmo S.p.A.

Equities

COSMO

IT0005487670

Market Closed - Borsa Italiana 16:44:59 14/05/2024 BST 5-day change 1st Jan Change
0.89 EUR 0.00% Intraday chart for Farmacosmo S.p.A. +7.23% +29.74%

Summary

  • From a short-term investment perspective, the company presents a deteriorated fundamental configuration.

Strengths

  • The stock, which is currently worth 2024 to 0.5 times its sales, is clearly overvalued in comparison with peers.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

Weaknesses

  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • Low profitability weakens the company.
  • For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
  • The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
  • For the past year, analysts have significantly revised downwards their profit estimates.
  • For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
  • Over the past four months, analysts' average price target has been revised downwards significantly.
  • The company's earnings releases usually do not meet expectations.

Ratings chart - Surperformance

Sector: Department Stores

1st Jan change Capi. Investor Rating ESG Refinitiv
+29.74% 37.28M -
+15.37% 51.69B
B
+37.34% 39.73B -
+14.21% 10.11B
B
+17.95% 8.7B
C
-21.37% 7.31B
C
+11.21% 6.38B
B-
-2.90% 5.78B
D+
+13.80% 5.38B
C
-51.24% 3.52B
B+
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
-
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. COSMO Stock
  4. Ratings Farmacosmo S.p.A.